Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn't yet been approved ...

An estimated 24 million Americans will use these weight loss drugs by 2035, posing significant challenges as well as ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame ...

A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

Instem, a global leader in IT solutions for life sciences, has announced the launch of its new Non-GLP Pathology Module for Provantis, the market share-leading in vivo preclinical study management ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Marble Falls, Texas - New telemedicine solution offers accessible, personalized weight management. Victory Select, the ...

Specialty drugs remain the leading factor in spending, even though they represent a small fraction of overall utilization." ...

Losing weight by dieting (restricting energy) includes, along with fat loss, losing lean mass, about half of which is ...